US-Roadshow Trip Details
Date & Route
March 17th–21st 2025
East Coast (Massachusetts)
March 24th–28th 2025
California
Meeting Highlights: What Prisys Offers
-
Reliable NHP Model across major Therapeutic Areas:
- Immunology: autoimmune, inflammation, fibrosis, skin, and respiratory.
- Hematology: bleeding, coagulation, thrombosis, and hematological disorders.
- Neuroscience: ischemic/hemorrhagic stroke, Parkinson's disease, and pain.
- Metabolism: obesity, NAFLD/NASH, type 2 diabetes, and chronic diseases.
- Ophthalmology: glaucoma, fundus neovascularization, retinitis disorders.
-
Platform Applications:
- Real-Time MRI Navigation (RT-iMRI): For precise drug delivery via convection-enhanced delivery (CED).
- AI-based NHP Behavior Analysis System: Quantifies disease manifestation, drug efficacy, and safety with markerless, stress-free monitoring.
- In vivo Imaging: MR, CT, PET-CT, DSA (x-ray), DEXA, doppler ultrasound, colonoscope, laparoscope, bronchoscope.
-
And more…
- Tailored NHP models or Co-development opportunities
- From early discovery to IND: efficacy, safety, PK, and biodistribution…
- NHP bio-sample harvest, storage, shipping, and/or analysis
Prisys Biotech's Primate Translational Research Center (PTRC)
PTRC is a facility specializing in non-human primate research to support drug discovery and development. Key resources include clinical surgery suites, advanced imaging platforms, BSL-2 labs, and AAALAC-accredited NHP housing and labs. Supported by a multidisciplinary team, PTRC offers integrated solutions to facilitate preclinical research across various therapeutic area
Don't miss this opportunity to explore how Prisys can contribute to your pipeline. Contact us at bd@prisysbiotech.com or use the link below to schedule a one-hour face-to-face meeting at your office during the specified period:
East Coast (Massachusetts)
